Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-14.00	18.61	21.64
Graham Fair Price	4.02	99609.16	95759.46
PEG	578.31	2.80	-0.41
Price/Book	-21.37	0.57	0.72
Price/Cash Flow	-40.56	22.40	37.69
Prices/Earnings	-24.75	9.07	12.05
Price/Sales	-23.59	0.62	0.81
Price/FCF	-40.56	22.40	37.69
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	3.75	0.11	0.11
Operating Margin	9.46	0.04	0.04
ROA	5.82	< 0.005	< 0.005
ROE	0.01	0.02	4.49
ROIC	0.01	0.01	9.88
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	< 0.005	0.02	-69.69
Dividends QOQ	-0.72	3.01	316.25
EBIT QOQ	-0.24	0.15	-39.21
EPS QOQ	-0.29	0.03	-88.91
FCF QOQ	-0.64	0.35	-46.02
Revenue QOQ	-0.05	0.05	3.72
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.99	1.12	12.70
Days Sales Outstanding (DSO)	57.76	57.86	0.18
Inventory Turnover	90.50	80.30	-11.27
Debt/Capitalization	0.44	0.44	0.17
Quick Ratio	0.79	0.85	8.41
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	164999.77	191678.90	16.17
Cash	24115.77	25164.82	4.35
Capex	-2292.61	2054.32	-10.39
Free Cash Flow	3159.88	4253.67	34.61
Revenue	146473.15	153379.91	4.72
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	0.88	0.86	-2.28
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	12.60	11.84	-6.03
Naive Interpretation	Member

06 - Financial Health · Bad

Rating